Reports of Biochemistry
and Molecular Biology
Thu, Nov 21, 2024
[Archive]
Volume 13, Issue 1 (Vol.13 No.1 Apr 2024)
rbmb.net 2024, 13(1): 31-39 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Jalili Shahri J, Saeed Modaghegh M H, Tanzadehpanah H, Ebrahimnejad M, Mahaki H. TH1/TH2 Cytokine Profile and Their Relationship with Hematological Parameters in Patients with Acute Limb Ischemia. rbmb.net 2024; 13 (1) :31-39
URL: http://rbmb.net/article-1-1362-en.html
URL: http://rbmb.net/article-1-1362-en.html
Jamal Jalili Shahri 
, Mohammad Hadi Saeed Modaghegh , Hamid Tanzadehpanah , Motahare Ebrahimnejad , Hanie Mahaki *
, Mohammad Hadi Saeed Modaghegh , Hamid Tanzadehpanah , Motahare Ebrahimnejad , Hanie Mahaki *
Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract: (410 Views)
Background: The progression of acute limb ischemia (ALI) is being significantly influenced by changes in immune system function. The study aimed to determine the dominant immune cell responses (Th1 or Th2) in ALI patients by measuring serum levels of IL-4, IL-12, and IFN-γ. Previous studies indicate altered cytokine levels in cerebral ischemia, but there is no prior research on these cytokines in ALI patients.
Methods: This study involved 34 patients with ALI and 34 healthy controls. Blood samples were analyzed for hematological factors such as erythrocyte sedimentation rate (ESR), white blood cell (WBC) count, red blood cell (RBC) count, platelet (Plt) count, hemoglobin (Hb), and hematocrit (HCT). The levels of serum cytokines IL-4, IL-12, and IFN-γ were measured in both patients and control subjects using enzyme-linked immunosorbent assay (ELISA). The statistical analyses were conducted using SPSS and GraphPad Prism.
Results: The results showed that serum levels of IL-4 in ALI patients did not significantly differ from those in control groups. Acute limb ischemia exhibited significantly elevated levels of IL-12 and IFN-γ compared to healthy individuals. In addition, no correlation between the production of cytokines and the hematological parameters was found.
Conclusion: Th1 responses are believed to play a role in the pathogenesis of ALI, but further research is needed to fully understand their exact role.
Methods: This study involved 34 patients with ALI and 34 healthy controls. Blood samples were analyzed for hematological factors such as erythrocyte sedimentation rate (ESR), white blood cell (WBC) count, red blood cell (RBC) count, platelet (Plt) count, hemoglobin (Hb), and hematocrit (HCT). The levels of serum cytokines IL-4, IL-12, and IFN-γ were measured in both patients and control subjects using enzyme-linked immunosorbent assay (ELISA). The statistical analyses were conducted using SPSS and GraphPad Prism.
Results: The results showed that serum levels of IL-4 in ALI patients did not significantly differ from those in control groups. Acute limb ischemia exhibited significantly elevated levels of IL-12 and IFN-γ compared to healthy individuals. In addition, no correlation between the production of cytokines and the hematological parameters was found.
Conclusion: Th1 responses are believed to play a role in the pathogenesis of ALI, but further research is needed to fully understand their exact role.
Type of Article: Original Article |
Subject:
Immunology
Received: 2024/03/16 | Accepted: 2024/07/1 | Published: 2024/10/22
Received: 2024/03/16 | Accepted: 2024/07/1 | Published: 2024/10/22
References
1. Obara H, Matsubara K, Kitagawa Y. Acute Limb Ischemia. Ann Vasc Dis. 2018;11(4):443-448. [DOI:10.3400/avd.ra.18-00074] [PMID] []
2. Narula N, Dannenberg AJ, Olin JW, Bhatt DL, Johnson KW, Nadkarni G, et al. Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia. J Am Coll Cardiol. 2018;72(18):2152-2163. [DOI:10.1016/j.jacc.2018.08.002] [PMID]
3. Tanzadehpanah H, Lotfian E, Avan A, Saki S, Nobari S, Mahmoodian R, et al. Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases. Biomed Pharmacother. 2023;166:115321. [DOI:10.1016/j.biopha.2023.115321] [PMID]
4. Mahaki H, Saeed Modaghegh MH, Nasr Isfahani Z, Amir Daddost R, Molaei P, Ahmadyousefi Y, et al. The role of peptide-based tumor vaccines on cytokines of adaptive immunity: a review. Int J Peptide Res Therap. 2021;27:2527-42. [DOI:10.1007/s10989-021-10270-4]
5. Tanzadehpanah H, Modaghegh MHS, Mahaki H. Key biomarkers in cerebral arteriovenous malformations: Updated review. J Gene Med. 2023;25(12):e3559. [DOI:10.1002/jgm.3559] [PMID]
6. DeLong JH, Ohashi SN, O'Connor KC, Sansing LH. Inflammatory Responses After Ischemic Stroke. Semin Immunopathol. 2022;44(5):625-648. [DOI:10.1007/s00281-022-00943-7] [PMID]
7. Molaei P, Mahaki H, Manoochehri H, Tanzadehpanah H. Binding Sites of Anticancer Drugs on Human Serum Albumin (HSA): A Review. Protein Pept Lett. 2022;29(8):651-675. [DOI:10.2174/0929866529666220426124834] [PMID]
8. Mahaki H, Tanzadehpanah H, Jabarivasal N, Sardanian K, Zamani A. A review on the effects of extremely low frequency electromagnetic field (ELF-EMF) on cytokines of innate and adaptive immunity. Electromagn Biol Med. 2019;38(1):84-95. [DOI:10.1080/15368378.2018.1545668] [PMID]
9. Hagag S, Kodous A, Shaaban HA. Molecular and Immunohistochemical Alterations in Breast Cancer Patients in Upper Egypt. Rep Biochem Mol Biol. 2023;11(4):532-546. [DOI:10.52547/rbmb.11.4.532] [PMID] []
10. Mahaki H, Jabarivasal N, Sardanian K, Zamani A. Effects of Various Densities of 50 Hz Electromagnetic Field on Serum IL-9, IL-10, and TNF-α Levels. Int J Occup Environ Med. 2020;11(1):24-32. [DOI:10.15171/ijoem.2020.1572] [PMID] []
11. Mahaki H, Jabarivasal N, Sardarian K, Zamani A. The effects of extremely low-frequency electromagnetic fields on c-Maf, STAT6, and RORα expressions in spleen and thymus of rat. Electromagn Biol Med. 2019;38(2):177-183. [DOI:10.1080/15368378.2019.1608832] [PMID]
12. Sardarian K, Maghsood AH, Farimani M, Hajiloii M, Saidijam M, Farahpour M, et al. Detection of Toxoplasma gondii B1 gene in placenta does not prove congenital toxoplasmosis. Hum Antibodies. 2019;27(1):31-35. [DOI:10.3233/HAB-180346] [PMID]
13. Tanzadehpanah H, Bahmani A, Hosseinpour Moghadam N, Gholami H, Mahaki H, Farmany A, Saidijam M. Synthesis, anticancer activity, and β-lactoglobulin binding interactions of multitargeted kinase inhibitor sorafenib tosylate (SORt) using spectroscopic and molecular modelling approaches. Luminescence. 2021;36(1):117-128. [DOI:10.1002/bio.3929] [PMID]
14. Lambertsen KL, Gregersen R, Meldgaard M, Clausen BH, Heibøl EK, Ladeby R, et al. A role for interferon-gamma in focal cerebral ischemia in mice. J Neuropathol Exp Neurol. 2004;63(9):942-55. [DOI:10.1093/jnen/63.9.942] [PMID]
15. Raphael I, Nalawade S, Eagar TN, Forsthuber TG. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine. 2015;74(1):5-17. [DOI:10.1016/j.cyto.2014.09.011] [PMID] []
16. Yousefzadeh H, Jabbari Azad F, Rastin M, Banihashemi M, Mahmoudi M. Expression of Th1 and Th2 Cytokine and Associated Transcription Factors in Peripheral Blood Mononuclear Cells and Correlation with Disease Severity. Rep Biochem Mol Biol. 2017;6(1):102-111.
17. Yan W, Li T, Yin T, Hou Z, Qu K, Wang N, et al. M2 macrophage-derived exosomes promote the c-KIT phenotype of vascular smooth muscle cells during vascular tissue repair after intravascular stent implantation. Theranostics. 2020;10(23):10712-10728. [DOI:10.7150/thno.46143] [PMID] []
18. Sardarian K, Maghsood AH, Farimani M, Hajiloii M, Saidijam M, Rezaeepoor M, et al. Evaluation of Toxoplasma gondii B1 gene in Placental Tissues of Pregnant Women with Acute Toxoplasmosis. Adv Biomed Res. 2018;7:119. [DOI:10.4103/abr.abr_58_18] [PMID] []
19. Thompson EA, Darrah PA, Foulds KE, Hoffer E, Caffrey-Carr A, Norenstedt S, et al. Monocytes Acquire the Ability to Prime Tissue-Resident T Cells via IL-10-Mediated TGF-β Release. Cell Rep. 2019;28(5):1127-1135.e4. [DOI:10.1016/j.celrep.2019.06.087] [PMID] []
20. Bobinski F, Teixeira JM, Sluka KA, Santos ARS. Interleukin-4 mediates the analgesia produced by low-intensity exercise in mice with neuropathic pain. Pain. 2018 Mar;159(3):437-450. [DOI:10.1097/j.pain.0000000000001109] [PMID] []
21. Liu X, Liu J, Zhao S, Zhang H, Cai W, Cai M, et al. Interleukin-4 Is Essential for Microglia/Macrophage M2 Polarization and Long-Term Recovery After Cerebral Ischemia. Stroke. 2016;47(2):498-504. [DOI:10.1161/STROKEAHA.115.012079] [PMID] []
22. Chyuan IT, Lai JH. New insights into the IL-12 and IL-23: From a molecular basis to clinical application in immune-mediated inflammation and cancers. Biochem Pharmacol. 2020;175:113928. [DOI:10.1016/j.bcp.2020.113928] [PMID]
23. Agnihotri SK, Kumar B, Jain A, Anjali A, Negi MPS, Sachan R, et al. Clinical Significance of Circulating Serum Levels of sCD95 and TNF-α in Cytoprotection of Cervical Cancer. Rep Biochem Mol Biol. 2022;10(4):711-721. [DOI:10.52547/rbmb.10.4.711] [PMID] []
24. Ahmadvand H, Yalameha B, Adibhesami G, Nasri M, Naderi N, Babaeenezhad E, Nouryazdan N. The Protective Role of Gallic Acid Pretreatment On Renal Ischemia-reperfusion Injury in Rats. Rep Biochem Mol Biol. 2019;8(1):42-48.
25. Kaur A. Erythrocyte Sedimentation Rate: Its Determinants and Relationship with Risk Factors Involved in Ischemic Stroke. Korean J Clin Lab Sci. 2022;54(1):1-8. [DOI:10.15324/kjcls.2022.54.1.1]
26. Ege T, Us MH, Sungun M, Duran E. Cytokine response in lower extremity ischaemia/reperfusion. J Int Med Res. 2004;32(2):124-31. [DOI:10.1177/147323000403200204] [PMID]
27. Ormstad H, Aass HC, Lund-Sørensen N, Amthor KF, Sandvik L. Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol. 2011;258(4):677-85. [DOI:10.1007/s00415-011-6006-0] [PMID] []
28. Fiotti N, Giansante C, Ponte E, Delbello C, Calabrese S, Zacchi T, et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis. 1999;145(1):51-60. [DOI:10.1016/S0021-9150(99)00013-1] [PMID]
29. Jaffer U, Wade RG, Gourlay T. Cytokines in the systemic inflammatory response syndrome: a review. HSR Proc Intensive Care Cardiovasc Anesth. 2010;2(3):161-75.
30. Yassin MM, Harkin DW, Barros D'Sa AA, Halliday MI, Rowlands BJ. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg. 2002;26(1):115-21. [DOI:10.1007/s00268-001-0169-2] [PMID]
31. Yu S, Cui W, Han J, Chen J, Tao W. Longitudinal change of Th1, Th2, and Th17 cells and their relationship between cognitive impairment, stroke recurrence, and mortality among acute ischemic stroke patients. J Clin Lab Anal. 2022;36(7):e24542. [DOI:10.1002/jcla.24542] [PMID] []
32. Bellavia S, Scala I, Rizzo PA, Brunetti V, Broccolini A, Della Marca G, et al. Th1/Th2 polarization of peripheral immune response in atherothrombotic and cardioembolic stroke: a prospective study. Sci Rep. 2022;12(1):16384. [DOI:10.1038/s41598-022-20515-x] [PMID] []
33. Zaremba J, Losy J. Interleukin-12 in acute ischemic stroke patients. Folia Neuropathol. 2006;44(1):59-66.
34. Halladin NL, Ekeløf S, Alamili M, Bendtzen K, Lykkesfeldt J, Rosenberg J, Gögenur I. Lower limb ischaemia and reperfusion injury in healthy volunteers measured by oxidative and inflammatory biomarkers. Perfusion. 2015;30(1):64-70. [DOI:10.1177/0267659114530769] [PMID]
35. Yassin MM, Barros D'Sa AA, Parks G, Abdulkadir AS, Halliday I, Rowlands BJ. Mortality following lower limb ischemia-reperfusion: a systemic inflammatory response? World J Surg. 1996;20(8):961-6; discussion 966-7. [DOI:10.1007/s002689900144] [PMID]
36. Jalkanen J, Hollmén M, Maksimow M, Jalkanen S, Hakovirta H. Serum cytokine levels differ according to major cardiovascular risk factors in patients with lower limb atherosclerosis. Cytokine. 2019;114:74-80. [DOI:10.1016/j.cyto.2018.11.001] [PMID]
37. Ye J, Wang Y, Wang Z, Liu L, Yang Z, Wang M, et al. Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges. Front Pharmacol. 2020;11:129. [DOI:10.3389/fphar.2020.00129] [PMID] []
38. Yan X, Zhang H, Fan Q, Hu J, Tao R, Chen Q, et al. Dectin-2 Deficiency Modulates Th1 Differentiation and Improves Wound Healing After Myocardial Infarction. Circ Res. 2017;120(7):1116-1129. [DOI:10.1161/CIRCRESAHA.116.310260] [PMID]
39. Zhu H, Hu S, Li Y, Sun Y, Xiong X, Hu X, Chen J, Qiu S. Interleukins and Ischemic Stroke. Front Immunol. 2022;13:828447. [DOI:10.3389/fimmu.2022.828447] [PMID] []
40. Cho K-S, Vu THK, Doesburg D, Chen DF. Suppression of Interferon-gamma protects retinal ischemia-induced neuron death. Invest Ophth Vis Sci. 2014;55(13):1897-.
41. Leung S, Liu X, Fang L, Chen X, Guo T, Zhang J. The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease. Cell Mol Immunol. 2010;7(3):182-9. [DOI:10.1038/cmi.2010.22] [PMID] []
42. Nagelkerken L. Role of Th1 and Th2 cells in autoimmune demyelinating disease. Braz J Med Biol Res. 1998;31(1):55-60. [DOI:10.1590/S0100-879X1998000100007] [PMID]
43. Chou FC, Shieh SJ, Sytwu HK. Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur J Immunol. 2009;39(9):2403-11. [DOI:10.1002/eji.200839177] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
